U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06883123) titled 'Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost' on March 12.
Brief Summary: A randomized, multi-site, parallel-group, prospective study of patients who are adults with a diagnosis of mild to moderate open-angle glaucoma (OAG), currently on an on-label use of combination topical medication of Cosopt and Latanoprost for a minimum of 1 month.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Open Angle Glaucoma
Intervention:
DRUG: Simbrinza 0.2%-1% Ophthalmic Suspension
brinzolamide and brimonidine tartrate
DRUG: Rocklatan 0.02%-0.005% Ophthalmic Solution
netarsudil and latanoprost
DRUG: Cosopt ...